Literature DB >> 26536497

IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination.

Ewa Oleszycka1, Hannah B T Moran1, Graham A Tynan1, Claire H Hearnden1, Graham Coutts2, Matthew Campbell3, Stuart M Allan2, Christopher J Scott4, Ed C Lavelle1,5.   

Abstract

Despite its long record of successful use in human vaccines, the mechanisms underlying the immunomodulatory effects of alum are not fully understood. Alum is a potent inducer of interleukin-1 (IL-1) secretion in vitro in dendritic cells and macrophages via Nucleotide-binding domain and leucine-rich repeat-containing (NLR) family, pyrin domain-containing 3 (NLRP3) inflammasome activation. However, the contribution of IL-1 to alum-induced innate and adaptive immune responses is controversial and the role of IL-1α following alum injection has not been addressed. This study shows that IL-1 is dispensable for alum-induced antibody and CD8 T cell responses to ovalbumin. However, IL-1 is essential for neutrophil infiltration into the injection site, while recruitment of inflammatory monocytes and eosinophils is IL-1 independent. Both IL-1α and IL-1β are released at the site of injection and contribute to the neutrophil response. Surprisingly, these effects are NLRP3-inflammasome independent as is the infiltration of other cell populations. However, while NLRP3 and caspase 1 were dispensable, alum-induced IL-1β at the injection site was dependent on the cysteine protease cathepsin S. Overall, these data demonstrate a previously unreported role for cathepsin S in IL-1β secretion, show that inflammasome formation is dispensable for alum-induced innate immunity and reveal that IL-1α and IL-1β are both necessary for alum-induced neutrophil influx in vivo.
© 2015 FEBS.

Entities:  

Keywords:  IL-1; aluminium adjuvant; cathepsin S; inflammasome

Mesh:

Substances:

Year:  2015        PMID: 26536497     DOI: 10.1111/febs.13546

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  24 in total

1.  Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.

Authors:  Ryan F Russell; Jacqueline U McDonald; Laura Lambert; John S Tregoning
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 2.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

3.  Effects of propofol on myocardial ischemia-reperfusion injury in rats with type-2 diabetes mellitus.

Authors:  Ying Wang; Xiuru Qi; Chunliang Wang; Danning Zhao; Hongjie Wang; Jianxin Zhang
Journal:  Biomed Rep       Date:  2016-11-09

4.  Topotecan Reduces Neuron Death after Spinal Cord Injury by Suppressing Caspase-1-Dependent Pyroptosis.

Authors:  Wu Jiang; Fan He; Guoming Ding; Junsong Wu
Journal:  Mol Neurobiol       Date:  2022-07-18       Impact factor: 5.682

5.  Adjuvant pretreatment with alum protects neonatal mice in sepsis through myeloid cell activation.

Authors:  J C Rincon; A L Cuenca; S L Raymond; B Mathias; D C Nacionales; R Ungaro; P A Efron; J L Wynn; L L Moldawer; S D Larson
Journal:  Clin Exp Immunol       Date:  2017-11-16       Impact factor: 4.330

6.  Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages.

Authors:  Caroline S Hughes; Liza M Colhoun; Baljinder K Bains; Joanne D Kilgour; Roberta E Burden; James F Burrows; Ed C Lavelle; Brendan F Gilmore; Christopher J Scott
Journal:  Part Fibre Toxicol       Date:  2016-04-23       Impact factor: 9.400

7.  The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation.

Authors:  Filipa Lebre; Rukmani Sridharan; Michael J Sawkins; Daniel J Kelly; Fergal J O'Brien; Ed C Lavelle
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

8.  Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis.

Authors:  Jaimar C Rincon; Russell B Hawkins; Mckenzie Hollen; Dina C Nacionales; Ricardo Ungaro; Philip A Efron; Lyle L Moldawer; Shawn D Larson
Journal:  Shock       Date:  2021-02-01       Impact factor: 3.533

9.  Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.

Authors:  Matthew Mold; Emma Shardlow; Christopher Exley
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

10.  Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn.

Authors:  Annette Scheid; Francesco Borriello; Carlo Pietrasanta; Helen Christou; Joann Diray-Arce; Matthew A Pettengill; Sweta Joshi; Ning Li; Ilana Bergelson; Tobias Kollmann; David J Dowling; Ofer Levy
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.